Hansen disease in the United States in the 21st Century: A review of the literature

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 6, 2007, Pages 982-986

  Anderson, Heather ^a   Stryjewska, Barbara ^b   Boyanton Jr , Bobby L ^a   Schwartz, Mary R ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; RIFAMPICIN;

CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEPROMIN TEST; LEPROSY; MOLECULAR PROBE; MONOTHERAPY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM LEPRAE; NONHUMAN; POLYMERASE CHAIN REACTION; REVIEW; SKIN BIOPSY; SYSTEMATIC REVIEW; UNITED STATES;

DERMATITIS; DIAGNOSIS, DIFFERENTIAL; GRANULOMA; HUMANS; LEPROSY; PREVALENCE; PUBMED; SARCOIDOSIS; UNITED STATES;

EID: 34250183097     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Pfeifer LA. A summary of Hansen's Disease in the United States-2002. Baton Rouge, La: National Hansen's Disease Programs; 2003.
2. Taylor JP, Vitek I, Enriquez V, Smedley JW. A continuing focus of Hansen's disease in Texas. Am J Trop Med Hyg. 1999;60:449-452.
3. Trautman JR. The history of leprosy. In: Hastings RC, ed. Leprosy. Edinburgh, Scotland: Churchill Livingstone; 1994:12-13.
4. Hartzell JD, Zapor M, Peng S, Straight T. Leprosy: a case series and review. South Med J. 2004;97:1252-1256.
5. Sugita Y. Leprosy. Clin Dermatol. 1995;13:235-243.
6. Rees R. Recent bacteriologic, immunologic and pathologic studies on experimental human leprosy in the mouse foot pad. Int J Lepr. 1965;33:646-655.
7. Abulafia J, Vignale RA. Leprosy: pathogenesis updated. Int J Dermatol. 1999; 38:321-334.
8. Sasaki S, Takeshita F, Okuda K, Ishii N. Mycobacterium leprae and leprosy: a compendium. Microbiol Immunol. 2001;45:729-736.
9. Sehgal VN. Leprosy. Dermatol Clin. 1994;12:629-644.
10. Bhattacharya SN, Sehgal VN. Leprosy in India. Clin Dermatol. 1999;17: 159-170.
11. Katoch VM. Advances in the diagnosis and treatment of leprosy. Expert Rev Mol Med. 2002;2002:1-14.
12. Moschella SL. An update on the diagnosis and treatment of leprosy. J Am Acad Dermatol. 2004;51:417-426.
13. 7th WHO Expert Committee on Leprosy, June 1997. Available at: http:// www.who.int/lep/exp/exp.htm. Accessed November 9, 2004.
14. Jacobson RR, Krahenbuhl JL. Leprosy. Lancet. 1999;353:655-660.
15. Cho S, Cellona RV, Villahermosa LG, et al. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin Diagn Lab Immunol. 2001;8:138-142.
16. Ustianowski AP, Lockwood DN. Leprosy: current diagnostic and treatment approaches. Curr Opin Infect Dis. 2003;16:421-427.
17. Williams DL, Gillis TP, Booth RJ, Looker D, Watson JD. The use of a specific DNA probe and polymerase chain reaction for the detection of Mycobacterium leprae. J Infect Dis. 1990;162:193-200.
18. Sharma RK, Katoch K, Shivannavar CT, et al. Comparison of probes targeting ribosomal RNA vs DNA in leprosy cases. Indian J Med Microbiol. 1996; 14:99-104.
19. Katoch VM. Molecular techniques for leprosy: present applications and future perspective. Indian J Lepr. 1999;71:45-59.
20. Katoch VM. New investigative techniques in leprosy. Dermatol Update. 1998:165-174.
21. Singh HB, Katoch K, Natrajan M, et al. Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline. Acta Leprol. 1999;11:179-182.
22. Kurabachew M, Wondimu A, Ryon JJ. Reverse transcription-PCR detection of Mycobacterium leprae in clinical specimens. J Clin Microbiol. 1998;36:1352-1356.
23. Lefmann M, Moter A, Schweickert B, Gobel UB. Misidentification of Mycobacterium leprae as Mycobacterium intracellular by the COBAS AMPLICOR M. intracellulare Test. J Clin Microbiol. 2005;43:1928-1929.
24. Rabinowitz LO, Zaim MT. A clinicopathologic approach to granulomatous dermatoses. J Am Acad Dermatol. 1996;35:588-600.
25. Glusac EJ, Shapiro PE. Noninfectious granulomas. In: Elder DE, Elenitsas R, Johnson BL, Murphy GF, eds. Lever's Histopathology of the Skin. 9th ed. Philadelphia, Pa: Lippincott-Raven; 2005:373-399.
26. Azulay RD. Histopathology of skin lesions in leprosy. Int J Lepr Other Mycobact Dis. 1971;39:244-250.
27. Gainsborough N, Hall SM, Hughes RA, Leibowitz S. Sarcoid neuropathy. J Neurol. 1991;238:177-180.
28. Lucas S. Bacterial diseases. In: Elder DE, Elenitsas R, Johnson BL, Murphy GF, eds. Lever's Histopathology of the Skin. 9th ed. Philadelphia, Pa: Lippincott-Raven; 2005:551-590.
29. Rongioletti F, Cerroni L, Massone C, Basso M, Ciambellotti A, Rebora A. Different histologic patterns of cutaneous granulomas in systemic lymphoma. J Am Acad Dermatol. 2004;51:600-605.
30. Wood C, Nickoloff BJ, Todes-Taylor NR. Pseudotumor resulting from atypical mycobacterial infection: a "histoid" variety of Mycobacterium avium-intracellulare complex infection. Am J Clin Pathol. 1985;83:524-527.